Jentadueto XR linagliptin/metformin extended release regulatory update

FDA approved an NDA from Boehringer for Jentadueto XR linagliptin/metformin extended release as an adjunct to diet and exercise to improve glycemic control in adult Type II diabetics when treatment wi...